Risk behaviors and risk factors for HIV infection among participants in the Bangkok Tenofovir Study, an HIV pre-exposure prophylaxis trial among people who inject drugs

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Martin, Michael ^a,b   Vanichseni, Suphak ^c   Suntharasamai, Pravan ^c   Sangkum, Udomsak ^c   Mock, Philip A ^a   Leethochawalit, Manoj ^d   Chiamwongpaet, Sithisat ^d   Gvetadze, Roman J ^b   Kittimunkong, Somyot ^a   Curlin, Marcel E ^a,b   Worrajittanon, Dararat ^a   McNicholl, Janet M ^b   Paxton, Lynn A ^b   Choopanya, Kachit ^c  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Bangkok Tenofovir Study Group   (Thailand)

^d Bangkok Metropolitan Administration   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

METHAMPHETAMINE; MIDAZOLAM; PLACEBO; TENOFOVIR; ADENINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PHOSPHONIC ACID DERIVATIVE;

ADULT; ARTICLE; CONDOM USE; CONTROLLED STUDY; DISEASE TRANSMISSION; DOUBLE BLIND PROCEDURE; DRUG ABUSE; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MEN WHO HAVE SEX WITH MEN; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SEXUAL BEHAVIOR; THAILAND; VIRUS TRANSMISSION; YOUNG ADULT; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; EPIDEMIOLOGY; HIGH RISK BEHAVIOR; HIV INFECTIONS; MIDDLE AGED; MULTICENTER STUDY; PSYCHOLOGY; SUBSTANCE-RELATED DISORDERS;

ADENINE; ADULT; ANTI-HIV AGENTS; DOUBLE-BLIND METHOD; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; ORGANOPHOSPHONATES; RISK-TAKING; SUBSTANCE-RELATED DISORDERS; THAILAND;

EID: 84899867651     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092809     Document Type: Article

References (32)

1. Weniger BG, Limpakarnjanarat K, Ungchusak K, Thanprasertsuk S, Choopanya K, et al. (1991) The epidemiology of HIV infection and AIDS in Thailand. AIDS 5 Suppl 2: S71-85.
2. Thailand Ministry of Public Health. National AIDS Prevention and Alleviation Committee. UNGASS Country Progress Report, Thailand. Thailand Ministry of Public Health, Department of Disease Control. http://data.unaids. org/pub/report/2010/thailand-2010-country-progress-report-en.pdf. Accessed 26 December 2013.
3. Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, et al. (2013) Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 381: 2083-2090.
4. Martin M, Vanichseni S, Suntharasamai P, Sangkum U, Chuachoowong R, et al. (2011) Enrollment characteristics and risk behaviors of injection drug users participating in the Bangkok Tenofovir Study, Thailand. PLoS One 6: e25127.
5. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, et al. (2010) Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 363: 2587-2599.
6. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, et al. (2012) Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 367: 399-410.
7. Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, et al. (2012) Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med 367: 423-434.
8. Sungkanuparph S, Techasathit W, Utaipiboon C, Chasombat S, Bhakeecheep S, et al. (2010) Thai national guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2010. Asian Biomedicine 4: 515-528.
9. Diggle PJ, Liang K, Zeger SL. (1994) Analysis of longitudinal data. Oxford: Oxford University Press.
10. Cox DR. (1972) Regression models and life-tables. Journal of the Royal Statistical Society Series B (Methodological) 34: 187-220.
11. Vanichseni S, Kitayaporn D, Mastro TD, Mock PA, Raktham S, et al. (2001) Continued high HIV-1 incidence in a vaccine trial preparatory cohort of injection drug users in Bangkok, Thailand. AIDS 15: 397-405. (Pubitemid 32163826)
12. Suntharasamai P, Martin M, Vanichseni S, van Griensven F, Mock PA, et al. (2009) Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003. Addiction 104: 235-242.
13. Family Health International and Ministry of Public Health Thailand. (2008) The Asian Epidemic Model (AEM) Projections for HIV/AIDS in Thailand: 2005-2025. Available: http://www.gfaidsboe.com/ Downloads/book/2554/ AsianEpidemicModelThailand20052025HV.pdf. Accessed 26 December 2013.
14. Smith DK, Grohskopf LA, Black RJ, Auerbach JD, Veronese F, et al. (2005) Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. MMWR Recomm Rep 54: 1-20.
15. van Griensven F, Varangrat A, Wimonsate W, Tanpradech S, Kladsawad K, et al. (2010) Trends in HIV Prevalence, Estimated HIV Incidence, and Risk Behavior Among Men Who Have Sex With Men in Bangkok, Thailand, 2003-2007. J Acquir Immune Defic Syndr 53: 234-39.
16. Brewer TF, Vlahov D, Taylor E, Hall D, Munoz A, et al. (1988) Transmission of HIV-1 within a statewide prison system. AIDS 2: 363-367. (Pubitemid 19008115)
17. Taylor A, Goldberg D, Emslie J, Wrench J, Gruer L, et al. (1995) Outbreak of HIV infection in a Scottish prison. BMJ 310: 289-292.
18. Choopanya K, Des Jarlais DC, Vanichseni S, Kitayaporn D, Mock PA, et al. (2002) Incarceration and risk for HIV infection among injection drug users in Bangkok. J Acquir Immune Defic Syndr 29: 86-94. (Pubitemid 34094312)
19. Buavirat A, Page-Shafer K, van Griensven GJ, Mandel JS, Evans J, et al. (2003) Risk of prevalent HIV infection associated with incarceration among injecting drug users in Bangkok, Thailand: case-control study. BMJ 326: 308.
20. Beyrer C, Jittiwutikarn J, Teokul W, Razak MH, Suriyanon V, et al. (2003) Drug use, increasing incarceration rates, and prison-associated HIV risks in Thailand. AIDS Behav 7: 153-161. (Pubitemid 36781510)
21. Dolan K, Kite B, Black E, Aceijas C, Stimson GV (2007) HIV in prison in low-income and middle-income countries. Lancet Infect Dis 7: 32-41. (Pubitemid 44940759)
22. Okie S (2007) Sex, drugs, prisons, and HIV. N Engl J Med 356: 105-108.
23. Wood E, Montaner J, Kerr T (2005) HIV risks in incarcerated injection-drug users. Lancet 366: 1834-1835. (Pubitemid 41690104)
24. Small W, Kain S, Laliberte N, Schechter MT, O'Shaughnessy MV, et al. (2005) Incarceration, addiction and harm reduction: inmates experience injecting drugs in prison. Subst Use Misuse 40: 831-843. (Pubitemid 40807525)
25. Dolan K, Rutter S, Wodak AD (2003) Prison-based syringe exchange programmes: a review of international research and development. Addiction 98: 153-158. (Pubitemid 36140366)
26. Pitisuttithum P, Gilbert P, Gurwith M, Heyward W, Martin M, et al. (2006) Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J Infect Dis 194: 1661-1671. (Pubitemid 44901996)
27. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, et al. (2009) Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 361: 2209-2220.
28. Wattana W, van Griensven F, Rhucharoenpornpanich O, Manopaiboon C, Thienkrua W, et al. (2007) Respondent-driven sampling to assess characteristics and estimate the number of injection drug users in Bangkok, Thailand. Drug Alcohol Depend 90: 228-233. (Pubitemid 47284716)
29. Johnston LG, Prybylski D, Raymond HF, Mirzazadeh A, Manopaiboon C, et al. (2013) Incorporating the Service Multiplier Method in Respondent-Driven Sampling Surveys to Estimate the Size of Hidden and Hard-to-Reach Populations: Case Studies From Around the World. Sex Transm Dis 40: 304-310.
30. Konings E, Bantebya G, Carael M, Bagenda D, Mertens T (1995) Validating population surveys for the measurement of HIV/STD prevention indicators. AIDS 9: 375-382.
31. Mastro TD, Kitayaporn D, Weniger BG, Vanichseni S, Laosunthorn V, et al. (1994) Estimating the number of HIV-infected injection drug users in Bangkok: a capture-recapture method. Am J Public Health 84: 1094-1099. (Pubitemid 24242479)
32. World Health Organization. (2009) WHO, UNODC, UNAIDS Technical Guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users. Available: http://www.unodc.org/documents/hiv- aids/WHO%20UNODC%20UNAIDS%20%20IDU%20Universal%20Access%20Target%20Setting% 20Guide%20-%20FINAL%20-%20Feb%2009.pdf. Accessed 26 December 2013.